Stock Research for BSPM

BSPM
Current Price

$3.8500


Latest Update: 2018-02-16 16:00:00

High
$ 3.8600
Low
$ 3.8500
Close
$ 3.8600
Volume
3802
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

BSPM Stock Chart & Research Data

The BSPM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BSPM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


BSPM Due diligence Resources & Stock Charts

The BSPM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BSPM Detailed Price Forecast - CNN Money CNN View BSPM Detailed Summary - Google Finance
Yahoo View BSPM Detailed Summary - Yahoo! Finance Zacks View BSPM Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View BSPM Trends & Analysis - Trade-Ideas Barrons View BSPM Major Holders - Barrons
NASDAQ View BSPM Call Transcripts - NASDAQ Seeking View BSPM Breaking News & Analysis - Seeking Alpha
Spotlight View BSPM Annual Report - CompanySpotlight.com OTC Report View BSPM OTC Short Report - OTCShortReport.com
TradeKing View BSPM Fundamentals - TradeKing Charts View BSPM SEC Filings - Bar Chart
WSJ View Historical Prices for BSPM - The WSJ Morningstar View Performance/Total Return for BSPM - Morningstar
MarketWatch View the Analyst Estimates for BSPM - MarketWatch CNBC View the Earnings History for BSPM - CNBC
StockMarketWatch View the BSPM Earnings - StockMarketWatch MacroAxis View BSPM Buy or Sell Recommendations - MacroAxis
Bullish View the BSPM Bullish Patterns - American Bulls Short Pains View BSPM Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View BSPM Stock Mentions - StockTwits PennyStocks View BSPM Stock Mentions - PennyStockTweets
Twitter View BSPM Stock Mentions - Twitter Invest Hub View BSPM Investment Forum News - Investor Hub
Yahoo View BSPM Stock Mentions - Yahoo! Message Board Seeking Alpha View BSPM Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for BSPM - SECform4.com Insider Cow View Insider Transactions for BSPM - Insider Cow
CNBC View BSPM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BSPM - OTC Markets
Yahoo View Insider Transactions for BSPM - Yahoo! Finance NASDAQ View Institutional Holdings for BSPM - NASDAQ


Stock Charts

FinViz View BSPM Stock Insight & Charts - FinViz.com StockCharts View BSPM Investment Charts - StockCharts.com
BarChart View BSPM Stock Overview & Charts - BarChart Trading View View BSPM User Generated Charts - Trading View


Latest Financial News for BSPM

Best Undervalued Stock in February
Posted on Sunday February 11, 2018

Companies, such as Biostar Pharmaceuticals, are deemed to be undervalued because their shares are currently trading below their true values. Investors can profit from the difference by investing in theseRead More...


Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification
Posted on Wednesday February 07, 2018

XIANYANG, China, Feb. 7, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced that its variable interest entity in China, Shaanxi Aoxing Pharmaceutical Co., Ltd. ("Aoxing"), has renewed its Good Manufacturing Practices (GMP) certificate and Pharmaceutical Production License. The Company received the renewed GMP certificate evidencing compliance on January 31, 2018.


Biostar Pharma Post Huge Gains, Pipeline Review, and a New Product
Posted on Thursday February 01, 2018

NEW YORK, NY / ACCESSWIRE / February 1, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...


Why Biostar Pharmaceuticals Inc (NASDAQ:BSPM) May Not Be As Efficient As Its Industry
Posted on Sunday January 28, 2018

Biostar Pharmaceuticals Inc’s (NASDAQ:BSPM) most recent return on equity was a substandard 2.66% relative to its industry performance of 11.58% over the past year. Though BSPM’s recent performance is underwhelming,Read More...


Biostar Pharmaceuticals Inc (NASDAQ:BSPM): Risks You Need To Consider Before ...
Simply Wall St - Feb 5, 2018
If you are a shareholder in Biostar Pharmaceuticals Inc's (NASDAQ:BSPM), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of your portfolio is important.
Acadian Asset Management Llc built an about 0.8% stake in Biostar ... - Post Analyst
Highly Traded Stock: Biostar Pharmaceuticals, Inc. (BSPM) - FactsReporter

Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) – Performance Evaluation
Nasdaq Journal - Feb 15, 2018
Shares of Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) closed the previous trading session at $4.65, experiencing a change of 3.59% with 874,183 shares trading hands.

Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification
PR Newswire (press release) - Feb 7, 2018
XIANYANG, China, Feb. 7, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and ...
Biostar Pharmaceuticals (BSPM) Stock: Gaining On GMP Certification News - CNA Finance
Biostar Pharmaceuticals, Inc. (BSPM)- Stocks Making Notable Moves - NASDAQ Times

Biostar Pharmaceuticals, Inc. (BSPM) held by 1 SEC 13F Filers
Post Analyst - Feb 12, 2018
Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) recovered 295.76% of its value since hitting low of $1.18. The recent move of 9.11% gain helped the stock to close at $4.67 when trading ended on 02/09/2018.
Biostar Pharmaceuticals, Inc. (BSPM) RSI Movement indicates stock could lead ... - Nasdaq Chronicle

Enter a stock symbol to view the stock details.